Company profile

Sanwa Kagaku Kenkyusho

Diversified pharma

Privately held: no public share price · Japan

Assets

(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Miglitol(Glyset)
Approved
Alpha-glucosidaseSmall molecule
Type 2 Diabetes
Upacicalcet(UPASITA)
Approved
Calcium-sensing receptor (CaSR)Small molecule
Chronic Kidney Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.